<DOC>
	<DOCNO>NCT00452400</DOCNO>
	<brief_summary>The primary objective study determine optimum dose ( ) BI 1744 CL inhalation solution deliver Respimat® inhaler four week patient chronic obstructive pulmonary disease ( COPD ) . The selection optimum dose ( ) base bronchodilator efficacy ( well help breathe ) , safety evaluation pharmacokinetic evaluation ( amount medication find blood ) .</brief_summary>
	<brief_title>Efficacy Safety 4 Weeks Treatment With Inhaled BI 1744 CL Patients With COPD .</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<criteria>1 . All patient must sign informed consent consistent ICHGCP guideline prior participation trial , include medication washout restriction 2 . All patient must diagnosis chronic obstructive pulmonary disease must meet follow spirometric criterion : Patients must relatively stable , moderate severe airway obstruction postbronchodilator FEV1 &amp; # 61619 ; 30 % predict normal &lt; 80 % predict normal postbronchodilator FEV1 / FVC &lt; 70 % Visit 1 3 . Male female patient , 40 year age old 4 . Patients must current exsmokers smoke history 10 pack year . Patients never smoke cigarette must exclude 5 . Patients must able perform technically acceptable pulmonary function test PEFR measurement , must able maintain record ( Patient Daily eDiary ) study period require protocol 6 . Patients must able inhale medication competent manner Respimat® inhaler meter dose inhaler ( MDI ) . Selection relevant exclusion criterion : 1 . Patients history asthma total blood eosinophil count 600/mm3 . 2 . Patients follow condition : diagnosis thyrotoxicosis diagnosis paroxysmal tachycardia ( &gt; 100 beat per minute ) mark baseline prolongation QT/QTc interval ( e.g . repeat demonstration QTc interval &gt; 450 m ) . history additional risk factor Torsade de Pointes ( TdP ) ( e.g . heart failure , hypokalemia , family history Long QT Syndrome ) 3 . Patients follow condition : history myocardial infarction within 1 year screen visit ( Visit 1 ) diagnosis clinically relevant cardiac arrhythmia know active tuberculosis malignancy patient undergone resection , radiation therapy chemotherapy within last five year ( patient treat basal cell carcinoma allow ) history lifethreatening pulmonary obstruction history cystic fibrosis clinically evident bronchiectasis history significant alcohol drug abuse 4 . Patients undergone thoracotomy pulmonary resection 5 . Patients regularly use daytime oxygen therapy one hour per day investigator 's opinion unable abstain use oxygen therapy clinic visit 6 . Patients complete pulmonary rehabilitation program six week prior Screening Visit ( Visit 1 ) patient currently pulmonary rehabilitation program 7 . Patients take investigational drug within one month six half life ( whichever great ) prior Screening Visit ( Visit 1 ) 8 . Pregnant nursing woman 9 . Women childbearing potential use highly effective method birth control 10 . Patients previously randomize study currently participate another study 11 . Patients unable comply medication restriction .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>